LINCS MCF 10A Common Project: Rolling-time-point sensitivity measures of the MCF 10A breast cell line to 8 small molecule perturbagens. Dataset 1 of 15: End-point cell counts and normalized growth rate inhibition values for all technical replicates of biological replicate 1. - Dataset (ID:20309)
Download: Excel (XLSX), Comma-separated (CSV)
| Cell | Small Molecule | Small Mol Concentration (uM) | Time Point (hr) | Total Cell Count Before Treatment | Total Cell Count After Treatment | Total Control Cell Count | Relative Cell Count | Normalized Growth Rate Inhibition Value | Assay Plate | Assay Well |
|---|---|---|---|---|---|---|---|---|---|---|
| MCF 10A-H2B-mCherry | Trametinib | 0.31623 | 29.33 | 771.67 | 1330 | 2939 | 0.4525 | 0.3260 | MN20160304_L01 | D06 |
| MCF 10A-H2B-mCherry | Trametinib | 0.31623 | 29.33 | 771.67 | 1493 | 2939 | 0.5079 | 0.4078 | MN20160304_L01 | H10 |
| MCF 10A-H2B-mCherry | Trametinib | 0.31623 | 31.55 | 771.67 | 1353 | 3196 | 0.4232 | 0.3150 | MN20160304_L01 | D06 |
| MCF 10A-H2B-mCherry | Trametinib | 0.31623 | 31.55 | 771.67 | 1402 | 3196 | 0.4386 | 0.3380 | MN20160304_L01 | H10 |
| MCF 10A-H2B-mCherry | Trametinib | 0.31623 | 33.78 | 771.67 | 1330 | 3499 | 0.3800 | 0.2835 | MN20160304_L01 | D06 |
| MCF 10A-H2B-mCherry | Trametinib | 0.31623 | 33.78 | 771.67 | 1421 | 3499 | 0.4060 | 0.3230 | MN20160304_L01 | H10 |
| MCF 10A-H2B-mCherry | Trametinib | 0.31623 | 36.00 | 771.67 | 1317 | 3884 | 0.3390 | 0.2577 | MN20160304_L01 | D06 |
| MCF 10A-H2B-mCherry | Trametinib | 0.31623 | 36.00 | 771.67 | 1509 | 3884 | 0.3884 | 0.3332 | MN20160304_L01 | H10 |
| MCF 10A-H2B-mCherry | Trametinib | 0.31623 | 38.22 | 771.67 | 1399 | 4299 | 0.3254 | 0.2714 | MN20160304_L01 | D06 |
| MCF 10A-H2B-mCherry | Trametinib | 0.31623 | 38.22 | 771.67 | 1502 | 4299 | 0.3493 | 0.3083 | MN20160304_L01 | H10 |
| MCF 10A-H2B-mCherry | Trametinib | 0.31623 | 40.44 | 771.67 | 1370 | 4738 | 0.2891 | 0.2451 | MN20160304_L01 | D06 |
| MCF 10A-H2B-mCherry | Trametinib | 0.31623 | 40.44 | 771.67 | 1510 | 4738 | 0.3187 | 0.2923 | MN20160304_L01 | H10 |
| MCF 10A-H2B-mCherry | Trametinib | 0.31623 | 42.67 | 771.67 | 1390 | 5155 | 0.2696 | 0.2396 | MN20160304_L01 | D06 |
| MCF 10A-H2B-mCherry | Trametinib | 0.31623 | 42.67 | 771.67 | 1492 | 5155 | 0.2894 | 0.2720 | MN20160304_L01 | H10 |
| MCF 10A-H2B-mCherry | Trametinib | 0.31623 | 44.89 | 771.67 | 1384 | 5541 | 0.2498 | 0.2280 | MN20160304_L01 | D06 |
| MCF 10A-H2B-mCherry | Trametinib | 0.31623 | 44.89 | 771.67 | 1531 | 5541 | 0.2763 | 0.2724 | MN20160304_L01 | H10 |
| MCF 10A-H2B-mCherry | Trametinib | 0.31623 | 47.11 | 771.67 | 1396 | 5941 | 0.2350 | 0.2230 | MN20160304_L01 | D06 |
| MCF 10A-H2B-mCherry | Trametinib | 0.31623 | 47.11 | 771.67 | 1517 | 5941 | 0.2553 | 0.2580 | MN20160304_L01 | H10 |
| MCF 10A-H2B-mCherry | Trametinib | 0.31623 | 49.33 | 771.67 | 1413 | 6392 | 0.2210 | 0.2193 | MN20160304_L01 | D06 |
| MCF 10A-H2B-mCherry | Trametinib | 0.31623 | 49.33 | 771.67 | 1533 | 6392 | 0.2398 | 0.2524 | MN20160304_L01 | H10 |
| MCF 10A-H2B-mCherry | Trametinib | 0.31623 | 51.55 | 771.67 | 1394 | 6829 | 0.2041 | 0.2068 | MN20160304_L01 | D06 |
| MCF 10A-H2B-mCherry | Trametinib | 0.31623 | 51.55 | 771.67 | 1548 | 6829 | 0.2267 | 0.2477 | MN20160304_L01 | H10 |
| MCF 10A-H2B-mCherry | Trametinib | 0.31623 | 53.77 | 771.67 | 1424 | 7256 | 0.1962 | 0.2086 | MN20160304_L01 | D06 |
| MCF 10A-H2B-mCherry | Trametinib | 0.31623 | 53.77 | 771.67 | 1558 | 7256 | 0.2147 | 0.2427 | MN20160304_L01 | H10 |
| MCF 10A-H2B-mCherry | Trametinib | 0.31623 | 55.99 | 771.67 | 1419 | 7690 | 0.1845 | 0.2016 | MN20160304_L01 | D06 |